Characterization of selective and potent PI3Kd inhibitor (PI3KDIN-015) for B-Cell malignances

Xiaochuan Liu, Aoli Wang, Xiaofei Liang, Cheng Chen, Juanjuan Liu, Zheng Zhao, Hong Wu, Yuanxin Deng, Li Wang, Beilei Wang, Jiaxin Wu, Feiyang Liu, Stacey M. Fernandes, Sophia Adamia, Richard M. Stone, Ilene A. Galinsky, Jennifer R. Brown, James D. Griffin, Shanchun Zhang, Teckpeng LohXin Zhang, Wenchao Wang, Ellen L. Weisberg, Jing Liu, Qingsong Liu

University of Science and Technology of China
Chinese Academy of Sciences
CHMFL-HCMTC Target Therapy Joint Laboratory
Harvard University
Hefei Cosource Medicine Technology Co. LTD.

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Sort by
Weight
Alphabetically

Characterization of selective and potent PI3Kd inhibitor (PI3KDIN-015) for B-Cell malignances

Fingerprint

Pharmacology, Toxicology and Pharmaceutical Science